GENENTECH'S COVID-19 RESPONSE
Genentech takes the health and safety of our patients, customers, employees and local communities very seriously. See below for information on how we're actively responding to the global COVID-19 pandemic.
News & Editorials
Leadership Lessons from COVID-19
An unexpected opportunity for leaders to adapt, grow and care for employees and patients.
Read the news about our EMPACTA trial of Actemra, focused on underserved and minority patients.
SARS-CoV-2 & Influenza A/B Test
Read the press release on the SARS-CoV-2 & Influenza A/B test from our parent company, Roche.
Global Manufacturing Collaboration
Learn about how Genentech and Roche are joining forces with Rengeron in the fight against COVID-19.
Supporting Patients Through and Beyond a Global Pandemic
Paving a new path to care during COVID-19.
Topline results from our Phase III trial on COVID-19 associated pneumonia.
Coronavirus and People of Color
The magnification of health disparities and what we must do now.
Pioneering A New Customer Engagement Model During Covid-19
Learn about how we are finding innovative ways to deliver on our mission during the pandemic.
Read the press release on the new IL-6 biomarker test from our parent company, Roche.
What Will We Learn From COVID-19?
A perspective on the actions we must take in response to and beyond the pandemic.
Read about our Phase III trial testing the combination of two investigational medicines for severe COVID-19 pneumonia.
Read the press release on the new Anti-SARS-CoV-2 antibody test from our parent company, Roche.
A Call for More Inclusive COVID-19 Research
Let’s work together to place diversity and inclusion at the forefront of COVID-19 research.
Lessons in Giving During a Global Pandemic
Genentech’s approach to giving during the COVID-19 crisis has been guided by three principles: Embrace equity. Engage employees. Think long-term.
Learn more about our commitment to help address the impacts of COVID-19 in our communities and across the U.S.
Learn more about our Phase III trial for hospitalized patients with severe COVID-19 pneumonia.
Read the press release on the SARS-CoV-2 test from our parent company, Roche.
If we all continue to work together, I believe science will ultimately prevail over this disease.
Information & Resources
Frequently Asked Questions
Read our responses to frequently asked questions regarding COVID-19 and Genentech.
Learn moreContact Information & Support Resources
View contact information and support resources for patients, medical professionals, and customers.
Learn morePatient Financial Support
We believe every person should get the Genentech medicine they need, and we offer programs to help make this happen.
Learn More